Insufficient scRNA-seq data for expression of ESX1 at single-cell level.
Insufficient scRNA-seq data for expression of ESX1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 0% | 0.05 | 2 / 2642 | 14% | 0.41 | 96 / 705 |
bladder | 0% | 0 | 0 / 21 | 5% | 0.31 | 25 / 504 |
esophagus | 0% | 0 | 0 / 1445 | 4% | 0.27 | 7 / 183 |
uterus | 0% | 0 | 0 / 170 | 4% | 0.24 | 17 / 459 |
breast | 0% | 0 | 0 / 459 | 3% | 0.13 | 30 / 1118 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.12 | 4 / 178 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.49 | 1 / 45 |
stomach | 0% | 0 | 0 / 359 | 2% | 0.23 | 6 / 286 |
lung | 0% | 0 | 0 / 578 | 2% | 0.23 | 24 / 1155 |
intestine | 0% | 0 | 0 / 966 | 1% | 0.08 | 7 / 527 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.03 | 5 / 430 |
skin | 0% | 0 | 0 / 1809 | 1% | 0.03 | 4 / 472 |
prostate | 0% | 0.23 | 1 / 245 | 0% | 0 | 0 / 502 |
liver | 0% | 0 | 0 / 226 | 0% | 0.00 | 1 / 406 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.00 | 1 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0000785 | Cellular component | chromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
Gene name | ESX1 |
Protein name | Extraembryonic spermatogenesis homeobox 1-like protein Homeobox protein ESX1 (Extraembryonic, spermatogenesis, homeobox 1) [Cleaved into: Homeobox protein ESX1-N; Homeobox protein ESX1-C] |
Synonyms | ESX1L ESX1R |
Description | FUNCTION: May coordinately regulate cell cycle progression and transcription during spermatogenesis. Inhibits degradation of polyubiquitinated cyclin A and cyclin B1 and thereby arrests the cell cycle at early M phase. ESXR1-N acts as a transcriptional repressor. Binds to the sequence 5'-TAATGTTATTA-3' which is present within the first intron of the KRAS gene and inhibits its expression. ESXR1-C has the ability to inhibit cyclin turnover. . |
Accessions | A6ZIT8 A6ZIU2 A6ZIU5 ENST00000372588.4 A6ZIS5 A6ZIS2 A6ZIS8 A6ZIU1 A6ZIT4 A6ZIT7 A6ZIU4 A6ZIU7 A6ZIT9 Q8N693 A6ZIT2 A6ZIU0 A6ZIS7 A6ZIV3 A6ZIT1 A6ZIV1 A6ZIV2 A6ZIU9 A6ZIV0 A6ZIT0 A6ZIU8 A6ZIU3 A6ZIS9 A6ZIT5 A6ZIS4 A6ZIT3 A6ZIT6 A6ZIU6 A6ZIS3 A6ZIS6 |